Oncotelic Therapeutcs Inc (OTLC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 1,741 | 0 | 0 | 0 | 0 |
| Gross Profit | 1,741 | N/A | N/A | N/A | N/A |
| Operating Expenses | 9,326 | 4,311 | 713 | 13,842 | 13,759 |
| Operating Income | -7,585 | -4,311 | -713 | -13,842 | -13,759 |
| Interest Expense | 1,998 | 750 | 0 | 0 | 0 |
| Other Income | -389 | -1,578 | 0 | 30 | 105 |
| Pre-tax Income | -9,972 | -6,638 | -713 | -13,812 | -13,654 |
| Net Income Continuous | -9,972 | -6,638 | -713 | -13,812 | -13,654 |
| Minority Interests | -469 | N/A | N/A | N/A | N/A |
| Net Income | $-9,503 | $-6,638 | $-713 | $-13,812 | $-13,654 |
| EPS Basic Total Ops | -0.11 | -0.11 | -0.12 | -0.52 | -0.51 |
| EPS Basic Continuous Ops | -0.11 | -0.11 | -0.12 | -0.52 | -0.51 |
| EPS Diluted Total Ops | -0.11 | -0.11 | -0.12 | -0.52 | -0.51 |
| EPS Diluted Continuous Ops | -0.11 | -0.11 | -0.12 | -0.52 | -0.51 |
| EPS Diluted Before Non-Recurring Items | -0.11 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-5,900 | $-3,504 | $-679 | $-13,833 | $-13,740 |